These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Positioning of electronic subretinal implants in blind retinitis pigmentosa patients through multimodal assessment of retinal structures. Kusnyerik A; Greppmaier U; Wilke R; Gekeler F; Wilhelm B; Sachs HG; Bartz-Schmidt KU; Klose U; Stingl K; Resch MD; Hekmat A; Bruckmann A; Karacs K; Nemeth J; Suveges I; Zrenner E Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3748-55. PubMed ID: 22562517 [TBL] [Abstract][Full Text] [Related]
6. Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential. Chalmel F; Léveillard T; Jaillard C; Lardenois A; Berdugo N; Morel E; Koehl P; Lambrou G; Holmgren A; Sahel JA; Poch O BMC Mol Biol; 2007 Aug; 8():74. PubMed ID: 17764561 [TBL] [Abstract][Full Text] [Related]
7. Controlled rod cell ablation in transgenic Xenopus laevis. Hamm LM; Tam BM; Moritz OL Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):885-92. PubMed ID: 18836175 [TBL] [Abstract][Full Text] [Related]
8. Retinal implant brings some sight to profound retinitis pigmentosa patients. Morrow T Manag Care; 2013 May; 22(5):54-5. PubMed ID: 23757835 [No Abstract] [Full Text] [Related]
9. Differential expression of cone opsin mRNA levels following experimental retinal detachment and reattachment. Rex TS; Lewis GP; Geller SF; Fisher SK Mol Vis; 2002 Apr; 8():114-8. PubMed ID: 11979236 [TBL] [Abstract][Full Text] [Related]
10. Unique characteristics of two types of retinitis pigmentosa patients with different rod sensitivities. Takahashi H; Miyake Y; Horiguchi M; Tomida N; Takakuwa H Jpn J Ophthalmol; 2005; 49(2):114-20. PubMed ID: 15838727 [TBL] [Abstract][Full Text] [Related]
11. Seeing the light. A glimmer of hope for retinal transplants. Rusting R Sci Am; 1990 Oct; 263(4):28, 30. PubMed ID: 2237371 [No Abstract] [Full Text] [Related]
12. A method and technical equipment for an acute human trial to evaluate retinal implant technology. Hornig R; Laube T; Walter P; Velikay-Parel M; Bornfeld N; Feucht M; Akguel H; Rössler G; Alteheld N; Lütke Notarp D; Wyatt J; Richard G J Neural Eng; 2005 Mar; 2(1):S129-34. PubMed ID: 15876648 [TBL] [Abstract][Full Text] [Related]
13. Implantation and explantation of a wireless epiretinal retina implant device: observations during the EPIRET3 prospective clinical trial. Roessler G; Laube T; Brockmann C; Kirschkamp T; Mazinani B; Goertz M; Koch C; Krisch I; Sellhaus B; Trieu HK; Weis J; Bornfeld N; Röthgen H; Messner A; Mokwa W; Walter P Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):3003-8. PubMed ID: 19420330 [TBL] [Abstract][Full Text] [Related]
14. [First success with a subretinal implant]. Hecker A Klin Monbl Augenheilkd; 2007 Apr; 224(4):222-3. PubMed ID: 17533683 [No Abstract] [Full Text] [Related]
15. Mapping cone- and rod-induced retinal responsiveness in macaque retina by optical imaging. Tsunoda K; Oguchi Y; Hanazono G; Tanifuji M Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3820-6. PubMed ID: 15452094 [TBL] [Abstract][Full Text] [Related]
17. [Retinitis pigmentosa]. Bruninx R; Lepièce G Rev Med Liege; 2020 Feb; 75(2):73-74. PubMed ID: 32030928 [TBL] [Abstract][Full Text] [Related]
18. A frameshift mutation in RPGR exon ORF15 causes photoreceptor degeneration and inner retina remodeling in a model of X-linked retinitis pigmentosa. Beltran WA; Hammond P; Acland GM; Aguirre GD Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1669-81. PubMed ID: 16565408 [TBL] [Abstract][Full Text] [Related]
19. Life history of cones in the rhodopsin-mutant P23H-3 rat: evidence of long-term survival. Chrysostomou V; Stone J; Valter K Invest Ophthalmol Vis Sci; 2009 May; 50(5):2407-16. PubMed ID: 19117918 [TBL] [Abstract][Full Text] [Related]
20. Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa. Komeima K; Rogers BS; Campochiaro PA J Cell Physiol; 2007 Dec; 213(3):809-15. PubMed ID: 17520694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]